Countries citing scholars working at Novartis (United States)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at Novartis (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (United States) more than expected).
Fields of papers published by authors at Novartis (United States)
This network shows the impact of papers affiliated with Novartis (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis (United States) at the time of their publication.
About Novartis (United States)
In recent decades, authors affiliated with Novartis (United States) have published 8.2k papers, which have received a total of 360.9k indexed citations . Scholars at this organization have produced 803 papers in Hematology, 689 papers in Genetics, 1.1k papers in Oncology, 502 papers in Rheumatology and 667 papers in Immunology on the topics of Chronic Myeloid Leukemia Treatments (370 papers), Chronic Lymphocytic Leukemia Research (299 papers), Advanced Breast Cancer Therapies (239 papers), Spondyloarthritis Studies and Treatments (226 papers), Heart Failure Treatment and Management (218 papers), Computational Drug Discovery Methods (208 papers), Asthma and respiratory diseases (201 papers) and Hemoglobinopathies and Related Disorders (193 papers). Their work is cited by papers focused on Hematology (23.7k citations), Genetics (21.2k citations), Oncology (52.5k citations), Molecular Biology (103.8k citations) and Endocrinology, Diabetes and Metabolism (23.2k citations). Authors at Novartis (United States) collaborate with scholars in United States, Switzerland and United Kingdom and have published in prestigious journals including Blood, Journal of Clinical Oncology, Value in Health, Annals of Oncology and Annals of the Rheumatic Diseases. Some of Novartis (United States)'s most productive authors include David J. Glass, Jerry Nedelman, Peter Atadja, Derek T. O’Hagan, William R. Sellers, Scott D. Solomon, James E. Foley, Taiping Chen, John J.V. McMurray and Anja Schweizer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact